Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis

Journal of Neuroimmunology

Volumn 230, Issue 1-2, 2011, Pages 33-41

  Gong, Nan ^a   Liu, Jianuo ^a   Reynolds, Ashley D ^a   Gorantla, Santhi ^a   Mosley, R Lee ^a   Gendelman, Howard E ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; CD4+CD25+ regulatory T cells; HIV 1; Macrophage; Neuroprotection; Single photon emission computed tomography

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; INDIUM 111;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD BRAIN BARRIER; CD4+ CD25+ T LYMPHOCYTE; CELL EXPANSION; CELL LABELING; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1 ENCEPHALITIS; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; ISOTOPE LABELING; MALE; MEMBRANE PERMEABILITY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VIRUS ENCEPHALITIS;

ANIMALS; BRAIN; CELL SEPARATION; DISEASE MODELS, ANIMAL; ENCEPHALITIS, VIRAL; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 78650966753     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.08.014     Document Type: Article

References (61)

1. Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Epstein L.G., Goodkin K., Gisslen M., Grant I., Heaton R.K., Joseph J., Marder K., Marra C.M., McArthur J.C., Nunn M., Price R.W., Pulliam L., Robertson K.R., Sacktor N., Valcour V., Wojna V.E. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799.
2. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., Roncarolo M.G. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 2006, 177:8338-8347.
3. Beilharz M.W., Sammels L.M., Paun A., Shaw K., van Eeden P., Watson M.W., Ashdown M.L. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. J. Immunol. 2004, 172:4917-4925.
4. Bennink R.J., van Montfrans C., de Jonge W.J., de Bruin K., van Deventer S.J., te Velde A.A. Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model. Nucl. Med. Biol. 2004, 31:93-101.
5. Bluestone J.A. Regulatory T-cell therapy: is it ready for the clinic? Nat. Rev. Immunol. 2005, 5:343-349.
6. Bluestone J.A., Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr. Opin. Immunol. 2005, 17:638-642.
7. Botti C., Negri D.R., Seregni E., Ramakrishna V., Arienti F., Maffioli L., Lombardo C., Bogni A., Pascali C., Crippa F., Massaron S., Remonti F., Nerini-Molteni S., Canevari S., Bombardieri E. Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur. J. Nucl. Med. 1997, 24:497-504.
8. Boyer O., Saadoun D., Abriol J., Dodille M., Piette J.C., Cacoub P., Klatzmann D. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004, 103:3428-3430.
9. Buckner C.M., Luers A.J., Calderon T.M., Eugenin E.A., Berman J.W. Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS. J. Neuroimmune Pharmacol. 2006, 1:160-181.
10. Carr A. Toxicity of antiretroviral therapy and implications for drug development. Nat. Rev. Drug Discov. 2003, 2:624-634.
11. Chadwick W., Magnus T., Martin B., Keselman A., Mattson M.P., Maudsley S. Targeting TNF-alpha receptors for neurotherapeutics. Trends Neurosci. 2008, 31:504-511.
12. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L., Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10:942-949.
13. Dittmer U., He H., Messer R.J., Schimmer S., Olbrich A.R., Ohlen C., Greenberg P.D., Stromnes I.M., Iwashiro M., Sakaguchi S., Evans L.H., Peterson K.E., Yang G., Hasenkrug K.J. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004, 20:293-303.
14. Dou H., Ellison B., Bradley J., Kasiyanov A., Poluektova L.Y., Xiong H., Maggirwar S., Dewhurst S., Gelbard H.A., Gendelman H.E. Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J. Neurosci. 2005, 25:8375-8385.
15. Engelhardt B., Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 2005, 26:485-495.
16. Fantini M.C., Becker C., Monteleone G., Pallone F., Galle P.R., Neurath M.F. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 2004, 172:5149-5153.
17. Fiorentino D.F., Bond M.W., Mosmann T.R. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170:2081-2095.
18. Garden G.A. Microglia in human immunodeficiency virus-associated neurodegeneration. Glia 2002, 40:240-251.
19. Gartner S. HIV infection and dementia. Science 2000, 287:602-604.
20. Gendelman H.E., Lipton S.A., Tardieu M., Bukrinsky M.I., Nottet H.S. The neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 1994, 56:389-398.
21. Ghiringhelli F., Menard C., Martin F., Zitvogel L. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol. Rev. 2006, 214:229-238.
22. Gorantla S., Liu J., Sneller H., Dou H., Holguin A., Smith L., Ikezu T., Volsky D.J., Poluektova L., Gendelman H.E. Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis. J. Immunol. 2007, 179:4345-4356.
23. Gorantla S., Liu J., Wang T., Holguin A., Sneller H.M., Dou H., Kipnis J., Poluektova L., Gendelman H.E. Modulation of innate immunity by copolymer-1 leads to neuroprotection in murine HIV-1 encephalitis. Glia 2008, 56:223-232.
24. Hara M., Kingsley C.I., Niimi M., Read S., Turvey S.E., Bushell A.R., Morris P.J., Powrie F., Wood K.J. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 2001, 166:3789-3796.
25. Hoffmann P., Eder R., Kunz-Schughart L.A., Andreesen R., Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells. Blood 2004, 104:895-903.
26. Hoffmann P., Ermann J., Edinger M., Fathman C.G., Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Exp. Med. 2002, 196:389-399.
27. Kolson D.L., Pomerantz R.J. AIDS dementia and HIV-1-induced neurotoxicity: possible pathogenic associations and mechanisms. J. Biomed. Sci. 1996, 3:389-414.
28. Komatsu N., Mariotti-Ferrandiz M.E., Wang Y., Malissen B., Waldmann H., Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl Acad. Sci. USA 2009, 106:1903-1908.
29. Kootstra N.A., van 't Wout A., Huisman H.G., Miedema F., Schuitemaker H. Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages. J. Virol. 1994, 68:6967-6975.
30. Kuyama J., McCormack A., George A.J., Heelan B.T., Osman S., Batchelor J.R., Peters A.M. Indium-111 labelled lymphocytes: isotope distribution and cell division. Eur. J. Nucl. Med. 1997, 24:488-496.
31. Letendre S., Ances B., Gibson S., Ellis R.J. Neurologic complications of HIV disease and their treatment. Top. HIV Med. 2007, 15:32-39.
32. Levings M.K., Sangregorio R., Roncarolo M.G. Human cd25(+)cd4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001, 193:1295-1302.
33. Liu J., Gong N., Huang X., Reynolds A.D., Mosley R.L., Gendelman H.E. Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration. J. Immunol. 2009, 182:3855-3865.
34. Mekala D.J., Geiger T.L. Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. Blood 2005, 105:2090-2092.
35. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoli C., Salvemini D., Perno C.F. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 2001, 24:411-416.
36. Nakamura K., Kitani A., Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 2001, 194:629-644.
37. Nelson B.H. IL-2, regulatory T cells, and tolerance. J. Immunol. 2004, 172:3983-3988.
38. Perry S.W., Norman J.P., Gelbard H.A. Adjunctive therapies for HIV-1 associated neurologic disease. Neurotox. Res. 2005, 8:161-166.
39. Persidsky Y., Limoges J., McComb R., Bock P., Baldwin T., Tyor W., Patil A., Nottet H.S., Epstein L., Gelbard H., Flanagan E., Reinhard J., Pirruccello S.J., Gendelman H.E. Human immunodeficiency virus encephalitis in SCID mice. Am. J. Pathol. 1996, 149:1027-1053.
40. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 2004, 22:929-979.
41. Pett S.L., Emery S. Immunomodulators as adjunctive therapy for HIV-1 infection. J. Clin. Virol. 2001, 22:289-295.
42. Poluektova L.Y., Munn D.H., Persidsky Y., Gendelman H.E. Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J. Immunol. 2002, 168:3941-3949.
43. Ralainirina N., Poli A., Michel T., Poos L., Andres E., Hentges F., Zimmer J. Control of NK cell functions by CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 2007, 81:144-153.
44. Reynolds A.D., Stone D.K., Mosley R.L., Gendelman H.E. Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets. J. Immunol. 2009, 182:4137-4149.
45. Reynolds A.D., Stone D.K., Mosley R.L., Gendelman H.E. Proteomic studies of nitrated alpha-synuclein microglia regulation by CD4+CD25+ T cells. J. Proteome Res. 2009, 8:3497-3511.
46. Ring S., Thome M., Pretsch L., Enk A.H., Mahnke K. Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions. J. Immunol. Methods 2007, 326:10-21.
47. Ritchie D., Mileshkin L., Wall D., Bartholeyns J., Thompson M., Coverdale J., Lau E., Wong J., Eu P., Hicks R.J., Prince H.M. In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma. Cancer Immunol. Immunother. 2007, 56:155-163.
48. Roberts E.S., Zandonatti M.A., Watry D.D., Madden L.J., Henriksen S.J., Taffe M.A., Fox H.S. Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS. Am. J. Pathol. 2003, 162:2041-2057.
49. Roncarolo M.G., Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat. Rev. Immunol. 2007, 7:585-598.
50. Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 2004, 22:531-562.
51. Schifitto G., Peterson D.R., Zhong J., Ni H., Cruttenden K., Gaugh M., Gendelman H.E., Boska M., Gelbard H. Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report. Neurology 2006, 66:919-921.
52. Tang Q., Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 2006, 212:217-237.
53. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004, 199:1455-1465.
54. Tarbell K.V., Petit L., Zuo X., Toy P., Luo X., Mqadmi A., Yang H., Suthanthiran M., Mojsov S., Steinman R.M. Dendritic cell-expanded, islet-specific CD4+CD25+CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J. Exp. Med. 2007, 204:191-201.
55. Tarbell K.V., Yamazaki S., Olson K., Toy P., Steinman R.M. CD25+CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 2004, 199:1467-1477.
56. Thornton A.M., Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998, 188:287-296.
57. Trenado A., Charlotte F., Fisson S., Yagello M., Klatzmann D., Salomon B.L., Cohen J.L. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J. Clin. Invest. 2003, 112:1688-1696.
58. Wahl S.M. Transforming growth factor-beta: innately bipolar. Curr. Opin. Immunol. 2007, 19:55-62.
59. Wan Y.Y., Flavell R.A. 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. Immunol. Rev. 2007, 220:199-213.
60. Wan Y.Y., Flavell R.A. TGF-beta and regulatory T cell in immunity and autoimmunity. J. Clin. Immunol. 2008, 28:647-659.
61. Wang H.Y., Lee D.A., Peng G., Guo Z., Li Y., Kiniwa Y., Shevach E.M., Wang R.F. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004, 20:107-118.